Drawing for C-PLEX

USPTO serial 97186337

C-PLEX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SALCIDO, JOHN CHARLES
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with C-PLEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Keith A. Weltsch

Keith A. Weltsch SCULLY SCOTT MURPHY & PRESSER400 GARDEN CITY PLAZASUITE 300GARDEN CITY, NY 11530

Goods and services

ClassDescriptionStatusFirst use
001Biological assays for research purposes; biological kits comprising arrays and reagents for detection and measurement of biological analytes for use in the fields of biological and diagnostic testing for industrial, scientific and/or research useACTIVE—
005Biological medical and veterinary assays for medical and diagnostic testing purposes; biological kits comprising arrays and reagents for detection and measurement of biological analytes and for use in the fields of biological and diagnostic testing for medical and/or veterinary useACTIVE—
009Multi-well plates that can be used in chemical or biological analysis for scientific, laboratory or medical research useACTIVE—
042Research and development in the fields of assays, selection, screening, testing, imaging and diagnostics; providing biological and biochemical sample testing for others through the performance of assays in the fields of scientific and clinical researchACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 2, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 2, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 13, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 12, 2025EX5GSOU EXTENSION 5 GRANTED—
Dec 11, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 3, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 2, 2025EXT5SOU EXTENSION 5 FILED—
Mar 4, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 4, 2025EX4GSOU EXTENSION 4 GRANTED—
Jan 3, 2025EXT4SOU EXTENSION 4 FILED—
Jan 3, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 2, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 2, 2024EX3GSOU EXTENSION 3 GRANTED—
Jul 2, 2024EXT3SOU EXTENSION 3 FILED—
Jul 2, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 4, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 2, 2024EX2GSOU EXTENSION 2 GRANTED—
Jan 2, 2024EXT2SOU EXTENSION 2 FILED—
Jan 2, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 29, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 27, 2023EX1GSOU EXTENSION 1 GRANTED—
Jun 27, 2023EXT1SOU EXTENSION 1 FILED—
Jun 27, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 3, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 8, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 8, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 19, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 30, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 26, 2022DOCKASSIGNED TO EXAMINER—
Dec 29, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 25, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance